Inflammation-triggering cellular pathway identified as potential new drug target for Alzheimer's disease

Updated on: March 09,2025

Inflammation-triggering cellular pathway identified as potential new drug target for Alzheimer's disease

Updated on:March 09,2025

Cortexyme publishes data on P. gingivalis ability to infect neurons

by IOS PressP. gingivalisbacteria (arrows), after invading a neuron, causes damage to the cellular infrastructure and synapses. Credit: Cortexyme, Inc.Cortexyme, Inc., a clinical stage biop

Updated on: March 26,2024

Cortexyme publishes data on P. gingivalis ability to infect neurons

by IOS PressP. gingivalisbacteria (arrows), after invading a neuron, causes damage to the cellular infrastructure and synapses. Credit: Cortexyme, Inc.Cortexyme, Inc., a clinical stage biop

Updated on:March 26,2024

Black people less likely to receive dementia-related medications

by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainBlack people are receiving medications for dementia less often than white people, according to a preliminary study released today,

Updated on: June 07,2024

Black people less likely to receive dementia-related medications

by American Academy of NeurologyCredit: Pixabay/CC0 Public DomainBlack people are receiving medications for dementia less often than white people, according to a preliminary study released today,

Updated on:June 07,2024

Amyloid is a less accurate marker for measuring severity, progression of Alzheimer's

by Perelman School of Medicine at the University of PennsylvaniaPET imaging using the radiotracers FDG and florbetapir to quantify cognitive decline in patients with Alzheimer’s disease (AD), mil

Updated on: May 22,2024

Amyloid is a less accurate marker for measuring severity, progression of Alzheimer's

by Perelman School of Medicine at the University of PennsylvaniaPET imaging using the radiotracers FDG and florbetapir to quantify cognitive decline in patients with Alzheimer’s disease (AD), mil

Updated on:May 22,2024

Recurrent brain trauma may increase Alzheimer's risk

by Radiological Society of North AmericaParametric maps of amyloid deposition in healthy control participants (A and B) and blast-exposed military instructors (C and D) at baseline (A and C) and

Updated on: June 01,2024

Recurrent brain trauma may increase Alzheimer's risk

by Radiological Society of North AmericaParametric maps of amyloid deposition in healthy control participants (A and B) and blast-exposed military instructors (C and D) at baseline (A and C) and

Updated on:June 01,2024

Gut could sound early warning alarm for motor neuron disease

by University of AberdeenCredit: Pixabay/CC0 Public DomainThe same proteins thought to contribute to motor neuron disease can be found in the gut many years before any brain symptoms occur, a new

Updated on: February 03,2024

Gut could sound early warning alarm for motor neuron disease

by University of AberdeenCredit: Pixabay/CC0 Public DomainThe same proteins thought to contribute to motor neuron disease can be found in the gut many years before any brain symptoms occur, a new

Updated on:February 03,2024

People with dementia encouraged to hang up the keys

by Kirsten O'leary,University of QueenslandResearchers have created a program to help people with dementia to hang up their car keys. Credit: University of QueenslandWhen people with dementi

Updated on: May 06,2024

People with dementia encouraged to hang up the keys

by Kirsten O'leary,University of QueenslandResearchers have created a program to help people with dementia to hang up their car keys. Credit: University of QueenslandWhen people with dementi

Updated on:May 06,2024

Psychotropic meds tied to risk for post-COVID dementia in seniors

Pre-COVID-19 psychotropic medication use is associated with higher risk for incident dementia following hospitalization for COVID-19 (post-COVID dementia) in older adults, according to a study publish

Updated on: July 04,2024

Psychotropic meds tied to risk for post-COVID dementia in seniors

Pre-COVID-19 psychotropic medication use is associated with higher risk for incident dementia following hospitalization for COVID-19 (post-COVID dementia) in older adults, according to a study publish

Updated on:July 04,2024

Alzheimer's disease: Viagra is seen as a potential treatment, but the research shows contradictory findings

by Ian Maidment and Hayley Gorton,The ConversationCredit: CC0 Public DomainArecent study reportedthat sildenafil, sold under the brand name Viagra, and other medicines from the same

Updated on: March 22,2024

Alzheimer's disease: Viagra is seen as a potential treatment, but the research shows contradictory findings

by Ian Maidment and Hayley Gorton,The ConversationCredit: CC0 Public DomainArecent study reportedthat sildenafil, sold under the brand name Viagra, and other medicines from the same

Updated on:March 22,2024

How much does dementia risk increase after traumatic brain injury?

by Public Library of ScienceThe WHO has predicted that TBI will become a leading cause of death and long-term illness during the next ten years. Already one per cent of the population in the United St

Updated on: May 13,2024

How much does dementia risk increase after traumatic brain injury?

by Public Library of ScienceThe WHO has predicted that TBI will become a leading cause of death and long-term illness during the next ten years. Already one per cent of the population in the United St

Updated on:May 13,2024

Genetics study finds ancestral background can affect Alzheimer's disease risk

by University of Miami Leonard M. Miller School of MedicineThe difference in APOE expression between African and European local ancestry carriers. University of Miami Leonard M. Miller School of

Updated on: March 09,2024

Genetics study finds ancestral background can affect Alzheimer's disease risk

by University of Miami Leonard M. Miller School of MedicineThe difference in APOE expression between African and European local ancestry carriers. University of Miami Leonard M. Miller School of

Updated on:March 09,2024

It is not clear whether new Alzheimer's drugs will make a difference at a population level, say researchers

byUniversity of CambridgeCredit: CC0 Public DomainCambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impa

Updated on: August 08,2024

It is not clear whether new Alzheimer's drugs will make a difference at a population level, say researchers

byUniversity of CambridgeCredit: CC0 Public DomainCambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impa

Updated on:August 08,2024